NEW YORK (GenomeWeb News) – The universities that make up the Big Ten athletic conference in the US have shed their rivalries and banded together to harness their biomedical science resources in a new cancer research consortium.

The Big Ten Cancer Research Consortium aims to leverage the infrastructures, expertise, and clinical facilities available in these universities' cancer centers in joint oncology trials, the University of Michigan Health System said today. The consortium plans to use molecular diagnostics to study how cancers work and how to treat them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.